top of page
Search
  • Writer's picturesiddhesh kapshikar
    • Oct 31, 2023
    • 4 min read

End-Stage Renal Disease (ESRD) Drugs Market, Global Outlook and Forecast 2023-2030

The global End-Stage Renal Disease (ESRD) Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.


This report aims to provide a comprehensive presentation of the global market for End-Stage Renal Disease (ESRD) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding End-Stage Renal Disease (ESRD) Drugs. This report contains market size and forecasts of End-Stage Renal Disease (ESRD) Drugs in global, including the following market information:


Global End-Stage Renal Disease (ESRD) Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)


Global End-Stage Renal Disease (ESRD) Drugs Market Sales, 2018-2023, 2024-2032, (K Pcs)

Global top five End-Stage Renal Disease (ESRD) Drugs companies in 2022 (%)


The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.

Calcium Succinate Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of End-Stage Renal Disease (ESRD) Drugs include CTI BioPharma Corp, Merck & Co Inc, Novartis AG, Prolong Pharmaceuticals LLC and VESSL Therapeutics Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the End-Stage Renal Disease (ESRD) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global End-Stage Renal Disease (ESRD) Drugs Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)

Global End-Stage Renal Disease (ESRD) Drugs Market Segment Percentages, by Type, 2022 (%)


  • Calcium Succinate

  • Mk-3866

  • Pacritinib

  • Sanguinate

  • Tesidolumab

  • Others


Global End-Stage Renal Disease (ESRD) Drugs Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)

Global End-Stage Renal Disease (ESRD) Drugs Market Segment Percentages, by Application, 2022 (%)


  • Hospital

  • Clinic

  • ICU

  • Others


Global End-Stage Renal Disease (ESRD) Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)

Global End-Stage Renal Disease (ESRD) Drugs Market Segment Percentages, By Region and Country, 2022 (%)


  • North America

  • US

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Russia

  • Nordic Countries

  • Benelux

  • Rest of Europe

  • Asia

  • China

  • Japan

  • South Korea

  • Southeast Asia

  • India

  • Rest of Asia

  • South America

  • Brazil

  • Argentina

  • Rest of South America

  • Middle East & Africa

  • Turkey

  • Israel

  • Saudi Arabia

  • UAE

  • Rest of Middle East & Africa


Competitor Analysis

The report also provides analysis of leading market participants including:


  • Key companies End-Stage Renal Disease (ESRD) Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)

  • Key companies End-Stage Renal Disease (ESRD) Drugs revenues share in global market, 2022 (%)

  • Key companies End-Stage Renal Disease (ESRD) Drugs sales in global market, 2018-2023 (Estimated), (K Pcs)

  • Key companies End-Stage Renal Disease (ESRD) Drugs sales share in global market, 2022 (%)


Further, the report presents profiles of competitors in the market, key players include:


  • CTI BioPharma Corp

  • Merck & Co Inc

  • Novartis AG

  • Prolong Pharmaceuticals LLC

  • VESSL Therapeutics Ltd


Outline of Major Chapters:

Chapter 1: Introduces the definition of End-Stage Renal Disease (ESRD) Drugs, market overview.

Chapter 2: Global End-Stage Renal Disease (ESRD) Drugs market size in revenue and volume.

Chapter 3: Detailed analysis of End-Stage Renal Disease (ESRD) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of End-Stage Renal Disease (ESRD) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global End-Stage Renal Disease (ESRD) Drugs capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Table of content

1 Introduction to Research & Analysis Reports 1.1 End-Stage Renal Disease (ESRD) Drugs Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global End-Stage Renal Disease (ESRD) Drugs Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global End-Stage Renal Disease (ESRD) Drugs Overall Market Size 2.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size: 2022 VS 2030 2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue, Prospects & Forecasts: 2018-2030 2.3 Global End-Stage Renal Disease (ESRD) Drugs Sales: 2018-2030 3 Company Landscape 3.1 Top End-Stage Renal Disease (ESRD) Drugs Players in Global Market 3.2 Top Global End-Stage Renal Disease (ESRD) Drugs Companies Ranked by Revenue 3.3 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Companies 3.4 Global End-Stage Renal Disease (ESRD) Drugs Sales by Companies 3.5 Global End-Stage Renal Disease (ESRD) Drugs Price by Manufacturer (2018-2023) 3.6 Top 3 and Top 5 End-Stage Renal Disease (ESRD) Drugs Companies in Global Market, by Revenue in 2022 3.7 Global Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Type 3.8 Tier 1, Tier 2 and Tier 3 End-Stage Renal Disease (ESRD) Drugs Players in Globa

0 views0 comments

Recent Posts

See All

Comments

bottom of page